Condition: Active Non-anterior, Non-infectious Uveitis · Sponsor: Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.
The purpose of this study is to find out the efficacy and safety of oral FXS5626 in participants with active, non-anterior (intermediate, posterior, or pan) non-infectious uveitis (NIU).
This description comes directly from the study's public registry record.
Yang · +86-23-89011876 · Peizengyang@126.com
Ye · +86-23-89011876 · 155322188@qq.com
Always discuss trial participation with your own doctor first.
| EC of the First Affiliated Hospital of Chongqing Medical University | Chongqing, Chongqing Municipality, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07552012